ENTO
Price
$0.54
Change
+$0.01 (+1.89%)
Updated
Jan 17 closing price
Capitalization
2.57M
PVLA
Price
$13.18
Change
-$0.04 (-0.30%)
Updated
Jan 17 closing price
Capitalization
147.9M
Ad is loading...

ENTO vs PVLA

Header iconENTO vs PVLA Comparison
Open Charts ENTO vs PVLABanner chart's image
Entero Therapeutics
Price$0.54
Change+$0.01 (+1.89%)
Volume$15.4K
Capitalization2.57M
Palvella Therapeutics
Price$13.18
Change-$0.04 (-0.30%)
Volume$15.96K
Capitalization147.9M
ENTO vs PVLA Comparison Chart
Loading...
ENTO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PVLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ENTO vs. PVLA commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENTO is a Hold and PVLA is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (ENTO: $0.54 vs. PVLA: $13.18)
Brand notoriety: ENTO and PVLA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ENTO: 6% vs. PVLA: 47%
Market capitalization -- ENTO: $2.57M vs. PVLA: $147.9M
ENTO [@Biotechnology] is valued at $2.57M. PVLA’s [@Biotechnology] market capitalization is $147.9M. The market cap for tickers in the [@Biotechnology] industry ranges from $352.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENTO’s FA Score shows that 1 FA rating(s) are green whilePVLA’s FA Score has 1 green FA rating(s).

  • ENTO’s FA Score: 1 green, 4 red.
  • PVLA’s FA Score: 1 green, 4 red.
According to our system of comparison, PVLA is a better buy in the long-term than ENTO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENTO’s TA Score shows that 3 TA indicator(s) are bullish while PVLA’s TA Score has 4 bullish TA indicator(s).

  • ENTO’s TA Score: 3 bullish, 4 bearish.
  • PVLA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, PVLA is a better buy in the short-term than ENTO.

Price Growth

ENTO (@Biotechnology) experienced а -8.46% price change this week, while PVLA (@Biotechnology) price change was -5.65% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.65%, and the average quarterly price growth was -1.89%.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PVLA($148M) has a higher market cap than ENTO($2.57M). PVLA has higher P/E ratio than ENTO: PVLA (6.69) vs ENTO (0.04). PVLA YTD gains are higher at: 9.833 vs. ENTO (-13.183).
ENTOPVLAENTO / PVLA
Capitalization2.57M148M2%
EBITDA-18.46MN/A-
Gain YTD-13.1839.833-134%
P/E Ratio0.046.691%
Revenue0N/A-
Total Cash367KN/A-
Total Debt160KN/A-
FUNDAMENTALS RATINGS
ENTO vs PVLA: Fundamental Ratings
ENTO
PVLA
OUTLOOK RATING
1..100
1786
VALUATION
overvalued / fair valued / undervalued
1..100
9
Undervalued
29
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
9134
P/E GROWTH RATING
1..100
8679
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ENTO's Valuation (9) in the null industry is in the same range as PVLA (29). This means that ENTO’s stock grew similarly to PVLA’s over the last 12 months.

ENTO's Profit vs Risk Rating (100) in the null industry is in the same range as PVLA (100). This means that ENTO’s stock grew similarly to PVLA’s over the last 12 months.

ENTO's SMR Rating (99) in the null industry is in the same range as PVLA (100). This means that ENTO’s stock grew similarly to PVLA’s over the last 12 months.

PVLA's Price Growth Rating (34) in the null industry is somewhat better than the same rating for ENTO (91). This means that PVLA’s stock grew somewhat faster than ENTO’s over the last 12 months.

PVLA's P/E Growth Rating (79) in the null industry is in the same range as ENTO (86). This means that PVLA’s stock grew similarly to ENTO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ENTOPVLA
RSI
ODDS (%)
N/A
Bullish Trend 6 days ago
80%
Stochastic
ODDS (%)
Bullish Trend 6 days ago
88%
Bearish Trend 6 days ago
90%
Momentum
ODDS (%)
Bearish Trend 6 days ago
86%
Bullish Trend 6 days ago
79%
MACD
ODDS (%)
Bearish Trend 6 days ago
90%
Bullish Trend 6 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 6 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 6 days ago
87%
Advances
ODDS (%)
Bullish Trend 13 days ago
82%
Bullish Trend 14 days ago
83%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 6 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 6 days ago
85%
Bearish Trend 6 days ago
89%
Aroon
ODDS (%)
N/A
Bearish Trend 6 days ago
86%
View a ticker or compare two or three
Ad is loading...
ENTO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PVLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA426.5012.68
+3.06%
Tesla
SPY597.585.94
+1.00%
SPDR® S&P 500® ETF Trust
AAPL229.981.72
+0.75%
Apple
BTC.X104408.070000-53.968750
-0.05%
Bitcoin cryptocurrency
GME27.51-0.21
-0.76%
GameStop Corp

ENTO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ENTO has been loosely correlated with IVVD. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if ENTO jumps, then IVVD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENTO
1D Price
Change %
ENTO100%
+2.25%
IVVD - ENTO
65%
Loosely correlated
-7.49%
SCPX - ENTO
39%
Loosely correlated
-1.86%
RLMD - ENTO
36%
Loosely correlated
-1.66%
CABA - ENTO
36%
Loosely correlated
+12.76%
GENFF - ENTO
25%
Poorly correlated
N/A
More

PVLA and

Correlation & Price change

A.I.dvisor indicates that over the last year, PVLA has been loosely correlated with MLEC. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if PVLA jumps, then MLEC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PVLA
1D Price
Change %
PVLA100%
-0.30%
MLEC - PVLA
58%
Loosely correlated
-1.29%
INMB - PVLA
31%
Poorly correlated
-4.02%
PROK - PVLA
24%
Poorly correlated
+0.61%
ENTO - PVLA
8%
Poorly correlated
+2.25%
LSB - PVLA
8%
Poorly correlated
+16.12%
More